F-group (family)
12.1.1.29 Glyco_hydro_30C
Ligands and drugs
221
Member domains
150
with ligand contacts (≤ 4 Å)
67.9% of members
124
with DrugDomain annotations
56.1% of members
117
with a DrugBank compound
52.9% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 12.1.1.29 belongs to X-group 12 Glycosyl hydrolase domain-like, which binds 6.5 ligand superclasses per 20 proteins, narrower than 68% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB00141 | NAG | N-Acetylglucosamine | 99 |
| DB00130 | GLN | L-Glutamine | 1 |
| DB00156 | THR | Threonine | 1 |
| DB01694 | TAR | D-tartaric acid | 1 |
| DB02175 | MLA | Malonic acid | 1 |
| DB03106 | — | scyllo-inositol | 1 |
| DB03740 | NDG | N-acetyl-alpha-D-glucosamine | 1 |
| DB04473 | FUC | alpha-L-fucose | 1 |
| DB09459 | TLA | L-tartaric acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 49 |
| CL | CHLORIDE ION | 5 |
| NAmetal | SODIUM ION | 4 |
| OD0 | (1~{S},2~{R},3~{S},6~{S})-6-fluoranylcyclohex-4-ene-1,2,3-triol | 2 |
| A1IB1 | 4-(phenylmethyl)piperidine | 1 |
| A1IBC | ~{N}-(cyclopropylmethyl)benzenesulfonamide | 1 |
| A1IBD | ~{N}-[(2~{S})-2-azanylpropyl]-4-methyl-benzenesulfonamide | 1 |
| A1IBE | ~{N}-[(2~{S})-3-azanyl-2-oxidanyl-propyl]-2-fluoranyl-benzenesulfonamide | 1 |
| A1IBG | ~{N}-[(2~{R})-3-azanyl-2-oxidanyl-propyl]-2-fluoranyl-benzenesulfonamide | 1 |
| A1IBI | (2~{S})-1-(2,6-dimethylphenoxy)propan-2-amine | 1 |
| A1IBO | ~{N}-[(2~{R})-2-azanyl-2-(3-prop-1-en-2-ylphenyl)ethyl]-3,5-bis(fluoranyl)-~{N}-methyl-benzenesulfonamide | 1 |
| A1IBP | ~{N}-[(2~{R})-2-azanyl-2-phenyl-ethyl]-3,5-bis(fluoranyl)-~{N}-methyl-benzenesulfonamide | 1 |
| A1IBQ | ~{N}-[(2~{S})-2-azanyl-2-phenyl-ethyl]-3,5-bis(fluoranyl)benzenesulfonamide | 1 |
| A1IBR | ~{N}-[(2~{S})-2-azanyl-2-phenyl-ethyl]-3,5-bis(fluoranyl)-~{N}-methyl-benzenesulfonamide | 1 |
| BAQ | pyrrolidin-2-one | 1 |
| DHI | D-HISTIDINE | 1 |
| GCU | alpha-D-glucopyranuronic acid | 1 |
| GLN | GLUTAMINE | 1 |
| HKW | 6-[3,3-dimethyl-2-[(1~{E},3~{E},5~{E})-5-(1,3,3-trimethylindol-2-ylidene)penta-1,3-dienyl]indol-1-ium-1-yl]-~{N}-[[1-[[(1~{S},2~{R},3~{R},4~{S},6~{S})-2,3,4,6-tetrakis(oxidanyl)cyclohexyl]methyl]-1,2,3-triazol-4-yl]methyl]hexanamide | 1 |
| MGmetal | MAGNESIUM ION | 1 |